Drawing for ISOLAGEN

USPTO serial 78959626

ISOLAGEN

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
GUSTASON, ANNE C
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ISOLAGEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Camille M. Miller

Camille M. Miller Cozen O'Connor1900 Market StreetPHILADELPHIA, PA 19103-3527UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001biochemicals namely, polypeptides for in vitro research use; amino acid sequences for laboratory or research useACTIVE—
003non-medicated skin care preparations, namely, serums, lotions, creams, gels, masks and sprays; cosmetic products, namely, skin cleaners, skin exfoliates, skin lotions and skin moisturizersACTIVE—
005vitamin supplements designed to promote youthful looking skin; pharmaceutical or medical preparations containing fibroblast cells for injecting under the skin for wrinkle reduction, reduction of acne conditions or reduction of scars of the skin or for injecting or surgically implanting into the gums or around the teeth; synthetic peptides for pharmaceutical purposes; amino acid sequences for medical or veterinary purposes; pharmaceutical products for the treatment of dermatologic conditions, wound healing, cancers, cardiovascular diseases, viral and infectious diseases, diseases of the immune system, genetic disorders, ophthalmic diseasesACTIVE—
035Retail store services and on-line retail store services for non-medicated skin care preparations, namely, serums, lotions, creams, gels, masks and sprays, for cosmetic products, namely, skin cleaners, skin exfoliates, skin lotions and skin moisturizers; for pharmaceutical or medical preparations containing fibroblast cells for injecting under the skin for wrinkle reduction, reduction of acne conditions or reduction of scars of the skin or for injecting or surgically implanting into the gums or around the teeth, and for pharmaceutical products for the treatment of dermatologic conditions, wound healing, cancers, cardiovascular diseases, viral and infectious diseases, diseases of the immune system, genetic disorders, ophthalmic diseasesACTIVE—
042Scientific research and development; cosmetic and pharmaceutical product research and development; chemical, biochemical and biological research and analysis; medical laboratory services, namely, growing and providing a supply of histocompatible fibroblast cells for use in medical, dental and cosmetic proceduresACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 16, 2010MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 15, 2010ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 21, 2009ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 14, 2009ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 8, 2009EX4GSOU EXTENSION 4 GRANTED—
Jun 3, 2009EXT4SOU EXTENSION 4 FILED—
Jun 3, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 23, 2008EX3GSOU EXTENSION 3 GRANTED—
Dec 23, 2008AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 10, 2008EXT3SOU EXTENSION 3 FILED—
Dec 10, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 13, 2008EX2GSOU EXTENSION 2 GRANTED—
Jun 9, 2008EXT2SOU EXTENSION 2 FILED—
Jun 9, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 6, 2007EX1GSOU EXTENSION 1 GRANTED—
Dec 6, 2007EXT1SOU EXTENSION 1 FILED—
Dec 6, 2007EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 10, 2007NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 17, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 28, 2007NPUBNOTICE OF PUBLICATION—
Feb 28, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 26, 2007ALIEASSIGNED TO LIE—
Jan 22, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 22, 2007XAECEXAMINER'S AMENDMENT ENTERED—
Jan 22, 2007GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 22, 2007CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 22, 2007ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jan 22, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 22, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 18, 2007DOCKASSIGNED TO EXAMINER—
Aug 29, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance